r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

EL

Evan Lippman

Insider · EVP, Business Development · TEVA

Evan Lippman files insider transactions with the SEC as an evp, business development of Teva Pharmaceutical Industries (TEVA). We hold 2 disclosed purchases and sales filed since 19 May 2025, 1 of them in the last 90 days.

  • Files forTEVA
  • Disclosed buys and sells2 in all, 1 in the last 90 days
  • Last disclosure19 August 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 14 May 2025 — 17 August 2026EVP, Business Development · Teva Pharmaceutical Industries (TEVA)11 Form 4 lines · source: SEC Form 4

Everything they disclosed

11 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.